Target intelligence / Profile preview

Neisseria meningitidis serogroups A, C, W, and Y capsular polysaccharides (ACWY capsular polysaccharides)

Target
ACWY capsular polysaccharides
Molecular classification
Polysaccharide, Capsular polysaccharide, Virulence factor
01

Overview

Capsular polysaccharides of Neisseria meningitidis serogroups A, C, W, and Y are surface-exposed sugar polymers that serve as major virulence factors, protecting the bacteria from host immune defenses. These polysaccharides are the targets of quadrivalent meningococcal conjugate vaccines, which elicit protective antibody responses that promote bacterial clearance through opsonization and complement activation. The chemical structure of each serogroup's polysaccharide is distinct, with serogroup A composed of N-acetyl mannosamine-1-phosphate, serogroup C of polysialic acid, and serogroups W and Y of sialic acid polymers with unique linkages. Conjugation to a carrier protein like tetanus toxoid or diphtheria toxoid enhances the immunogenicity of these polysaccharides, especially in infants and young children.

Other names
N. meningitidis A capsular polysaccharideN. meningitidis C capsular polysaccharideN. meningitidis W capsular polysaccharideN. meningitidis Y capsular polysaccharideMenA capsular polysaccharideMenC capsular polysaccharideMenW capsular polysaccharideMenY capsular polysaccharide
02

Mechanism of action

Vaccine-induced antibodies bind to the capsular polysaccharides, promoting complement activation and opsonophagocytosis, leading to bacterial clearance.

03

Biological functions

Immune evasionBacterial virulenceTarget for antibody-mediated immunityOpsonization
04

Disease associations

Invasive meningococcal diseaseMeningitisSepticemia
05

Safety considerations

Injection site reactionsFeverRare cases of Guillain-Barré syndrome
06

Interacting drugs

Quadrivalent meningococcal conjugate vaccines (e.g., Menactra, Menveo)
07

Biomarkers

Antibody titers against serogroups A, C, W, and Y

Beyond the preview

Go deeper on Neisseria meningitidis serogroups A, C, W, and Y capsular polysaccharides (ACWY capsular polysaccharides).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis serogroups A, C, W, and Y capsular polysaccharides (ACWY capsular polysaccharides).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call